H-L-Phg-OtBu*HCl

H-L-Phg-OtBu*HCl is an L-phenylglycine tert-butyl ester hydrochloride, functioning as a chiral amino acid ester building block with a stereogenic center at the α-carbon and a side chain bearing a benzyl-like aromatic ring. The molecule contains an esterified carboxyl group (OtBu) that can be manipulated under acid/base conditions, while the amino functionality is present as a hydrochloride salt that supports controlled handling and can be converted into an N-protected form for peptide coupling. The aromatic phenylglycine side chain introduces hydrophobic and π-interaction features that are frequently leveraged in peptide analog design and binding-site probing. The salt form and ester identity make the compound a practical intermediate for protected amino acid synthesis, enabling downstream transformations toward amide formation, side-chain functionalization, and stereochemically defined peptide fragments.

1. Peptide Synthesis

H-L-Phg-OtBu*HCl is applied in peptide building block preparation where the L-configuration at the α-carbon preserves stereochemical integrity during coupling chemistry. The amino group as a hydrochloride salt can be managed to enable conversion to an N-protected amino acid derivative, while the tert-butyl ester provides a C-terminal handle compatible with peptide coupling strategies after appropriate activation. The phenylglycine aromatic side chain can be incorporated into growing sequences to tune hydrophobic contacts and conformational preferences in peptide synthesis workflows. The resulting protected phenylglycine ester or its derivatives can be used as defined coupling partners for assembling peptide bonds and generating stereochemically consistent peptide fragments.

2. Chiral Amino Acid Intermediate

H-L-Phg-OtBu*HCl serves as a chiral amino acid intermediate for stereoselective synthesis routes that require an L-phenylglycine framework. The α-stereocenter and the aromatic side chain allow controlled downstream derivatization, including conversion of the amino functionality into protected forms and transformation of the ester into activated intermediates for amide bond construction. The tert-butyl ester group can be selected to match protecting-group strategies that separate C-terminal reactivity from N-terminal manipulation, supporting orthogonal protection planning. The hydrochloride salt form further aids reproducible handling during intermediate preparation, enabling consistent access to chiral phenylglycine-containing scaffolds for fine chemical synthesis.

3. Peptidomimetics And SAR Studies

H-L-Phg-OtBu*HCl is utilized in peptidomimetic construction and structure-activity relationship studies where phenylglycine residues are incorporated to modulate binding interactions through aromatic and conformational effects. The benzyl-like phenyl side chain can participate in π-stacking and hydrophobic recognition, while the amino acid backbone supports conversion into amide-linked analogs and constrained derivatives. The ester functionality supports stepwise synthesis of C-terminal variants, including preparation of fragments that can be coupled into peptide analogs or cyclization precursors. The stereodefined L-configuration enables generation of analog series that maintain consistent stereochemical context for SAR-focused chemical biology and medicinal chemistry research.

4. Side-Chain Functionalization

H-L-Phg-OtBu*HCl can be applied to side-chain functionalization workflows that start from a phenylglycine aromatic motif. The aromatic ring provides a platform for electrophilic aromatic substitution, cross-coupling, or further elaboration into substituted phenylglycine derivatives, while the amino acid ester and chiral center support retention of the backbone during modification. The tert-butyl ester enables selective deprotection or activation depending on the chosen synthetic sequence, allowing side-chain derivatization without premature disruption of the carboxyl functionality. The resulting functionalized phenylglycine intermediates can feed into downstream peptide analog construction, biochemical probe synthesis, and scaffold diversification for applied amino acid chemistry.

5. Pharmaceutical Intermediate Preparation

H-L-Phg-OtBu*HCl is suitable for pharmaceutical intermediate preparation in fine chemical manufacturing contexts that require a stereochemically defined phenylglycine building block. The protected amino acid ester framework supports conversion into N-protected derivatives and subsequent coupling intermediates used to assemble amide-containing drug-like molecules or peptide-derived intermediates. The hydrochloride salt form and the tert-butyl ester identity align with process chemistry needs for controlled reactivity management, enabling separation of salt formation, protection/deprotection steps, and coupling-ready intermediate generation. The chiral phenylglycine core can be carried forward into downstream manufacturing steps to produce defined intermediates for peptide-based or peptidomimetic synthetic programs.

6. Analytical Research Standards

H-L-Phg-OtBu*HCl is employed in analytical research as a stereochemically defined reference material for method development and impurity profiling related to amino acid ester and protected amino acid derivatives. The presence of the L-α-center and the aromatic phenylglycine side chain provides a structurally specific signal for chromatographic and spectrometric characterization of related intermediates. The ester and salt forms allow targeted monitoring of protecting-group stability, conversion states, and deprotection endpoints during synthetic sequences. The compound can therefore serve as a practical benchmark for verifying identity and stereochemical consistency across protected amino acid synthesis, peptide coupling chemistry, and downstream intermediate preparation.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines